N@N

XenoPort to Present at the 2010 Citi Health Care Conference

^{Published on 2010-05-18 07:05:24 - Market Wire}
 

SANTA CLARA, Calif.--([ BUSINESS WIRE ])--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2010 Citi Investment Research Global Health Care Conference. The live presentation will occur at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) on Wednesday, May 26, 2010. A replay of the presentation will also be available.

To access the live presentation via the Web, please go to [ www.XenoPort.com ]. Please connect to the Web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the Webcast.

A replay of the Webcast can be accessed for a minimum of one month and will be available approximately 24 hours after the live presentation.

About XenoPort

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the bodya™s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is developing its lead product candidate in collaboration with Astellas Pharma Inc. and GlaxoSmithKline. XenoPorta™s product candidates are being studied for the potential treatment of moderate-to-severe primary restless legs syndrome, neuropathic pain, migraine headaches, gastroesophageal reflux disease, spasticity and Parkinsona™s disease.

To learn more about XenoPort, please visit the Web site at [ www.XenoPort.com ].

XenoPort is a registered trademark.

XNPT2G